Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Jane Huang Insider Profile

11 Followers

Jane Huang, Director at Protara Therapeutics, holds ― shares in Protara Therapeutics (Ticker: TARA), holds 86.92K shares in Prelude Therapeutics (Ticker: PRLD), holds 160.06K shares in BeOne Medicines (Ticker: ONC).

Jane Huang's Trading History

PRLDPrelude Therapeutics		Oct 07, 2025President, CMOUninformative Buy8.85K$337.24K
ONCBeOne Medicines		Dec 16, 2021CMO, HematologyUninformative Buy179.94K$59.27M
TARAProtara Therapeutics		―Director――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Jane Huang insider profile FAQ

What is the percentage of profitable transactions made by Jane Huang?
The percentage of profitable transactions made by Jane Huang is 57%.
What is the average return per transaction made by Jane Huang?
The average return per transaction made by Jane Huang is 4.10%.
What stocks does Jane Huang hold?
Jane Huang holds: TARA, ONC, PRLD stocks.
What was Jane Huang's most profitable transaction?
Jane Huang’s most profitable transaction was an Informative Sell of ONC stock on June 9, 2021. The return on the trade was 56.60%.
What is Jane Huang's role in Protara Therapeutics?
Jane Huang's role in Protara Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.